Evidence mapPaperPMID 41788682Full record

ArticleFrontiers in nutrition2026

Serum

Nanaka Ando, Naohisa Nosaka, Kazuhiko Kato

Abstract read
In one paragraph

Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nanaka AndoStrategic Invention R&D, The Nisshin OilliO Group, Ltd., Yokohama, Kanagawa, Japan.
Naohisa NosakaStrategic Invention R&D, The Nisshin OilliO Group, Ltd., Yokohama, Kanagawa, Japan.
Kazuhiko KatoKato Clinic, Komae, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Our previous study showed that Methods: We conducted a Results: No significant correlation was found between ALA intake and serum n-3 fatty acid concentrations. Serum ALA correlated positively with serum docosapentaenoic acid (DPA) ( Discussion: This study suggests substantial inter-individual variation in the relationship between ALA intake and serum ALA concentration. Furthermore, it suggests that serum ALA concentration, rather than ALA intake, may be more closely associated with vascular stiffness, as assessed by baPWV. Clinical trial registration: https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000060078, identifier UMIN000052677.

Indexed as

arterial stiffnessbaPWVcardiovascular diseaselipid absorptionlipid metabolismomega-3 fatty acidspost hoc analysisα-Linolenic acid

Identifiers

PMID41788682
PMCPMC12958356

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.